カテゴリー： Transparency Market Research, 世界, 医療/バイオ

医療用食品の世界市場2023～2031：製品別、投与経路別

◆英語タイトル：Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23MA058）◆商品コード：TMR23MA058
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年3月14日
◆ページ数：232
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界の医療用食品市場規模が、2023年の230億ドルから2031年に440億ドルとなり、予測期間中に年平均成長率7.5%で拡大すると展望しています。本書は、医療用食品の世界市場にフォーカスし、市場状況や今後の動向などをまとめた資料です。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（丸薬、粉末、液体、その他）分析、疾患別（希少疾病、がん、神経・精神疾患、代謝性疾患、その他）分析、投与経路別（経口、経腸）分析、流通チャネル別（薬局・ドラックストア、オンライン、スーパーマーケット＆ハイパーマーケット、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、Nutricia (Danone)、Nestlé S.A.、Abbott Laboratories、Mead Johnson Nutrition、Fresenius Kabi、Friso、Morinaga Milk Industry、Primus Pharmaceuticals, Inc.、Targeted Medical Pharma, Inc.、Medtrition, Inc.などの情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界の医療用食品市場規模：製品別
- 丸薬型医療用食品の市場規模
- 粉末型医療用食品の市場規模
- 液体型医療用食品の市場規模
- その他製品の市場規模
・世界の医療用食品市場規模：疾患別
- 希少疾病における市場規模
- がんにおける市場規模
- 神経・精神疾患における市場規模
- 代謝性疾患における市場規模
- その他疾患における市場規模
・世界の医療用食品市場規模：投与経路別
- 経口投与における市場規模
- 経腸投与における市場規模
・世界の医療用食品市場規模：流通チャネル別
- 薬局・ドラックストアチャネルの市場規模
- オンラインチャネルの市場規模
- スーパーマーケット＆ハイパーマーケットチャネルの市場規模
- その他チャネルの市場規模
・世界の医療用食品市場規模：地域別
- 北米の医療用食品市場規模
- ヨーロッパの医療用食品市場規模
- アジア太平洋の医療用食品市場規模
- 中南米の医療用食品市場規模
- 中東・アフリカの医療用食品市場規模
・競争状況

Medical Foods Market – Scope of Report
TMR’s report on the global medical foods market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global medical foods market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical foods market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the medical foods market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical foods market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical foods market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical foods market.

The report delves into the competitive landscape of the global medical foods market. Key players operating in the global medical foods market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical foods market profiled in this report.

Key Questions Answered in Global Medical Foods Market Report
• What is the sales/revenue generated by medical foods across all regions during the forecast period?
• What are the opportunities in the global medical foods market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Medical Foods Market – Research Objectives and Research Approach
The comprehensive report on the global medical foods market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical foods market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical foods market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Foods Market
4. Market Overview
    4.1. Introduction
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
5. Key Insights
    5.1. Important market developments
    5.2. Top 3 Players Operating in the Market Space
    5.3. New competitive market entrants
    5.4. Medical food regulation overview
    5.5. Reimbursement Scenario
    5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples
6. Global Medical Foods Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Pills
        6.3.2. Powder
        6.3.3. Liquid
        6.3.4. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Foods Market Analysis and Forecast, by Disease Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Disease Type, 2017–2031
        7.3.1. Orphan Disease
            7.3.1.1. Duchenne Muscular Dystrophy (DMD)
            7.3.1.2. Sickle Cell Anemia
            7.3.1.3. Hemophilia
            7.3.1.4. Others
        7.3.2. Cancer
        7.3.3. Neurological & Psychological Disorders
        7.3.4. Metabolic Disorders
        7.3.5. Pain Management
        7.3.6. Gastrointestinal Disorders
        7.3.7. Ophthalmology
        7.3.8. Diabetes
        7.3.9. Phenylketonuria (PKU)
        7.3.10. Epilepsy
    7.4. Market Attractiveness Analysis, by Disease Type
8. Global Medical Foods Market Analysis and Forecast, by Route of Administration
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Route of Administration, 2017–2031
        8.3.1. Oral
        8.3.2. Enteral
    8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by Distribution Channel, 2017–2031
        9.3.1. Pharmacies & Drug Stores
        9.3.2. Online Channels
        9.3.3. Supermarkets & Hypermarkets
        9.3.4. Others
    9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Medical Foods Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region
11. North America Medical Foods Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Pills
        11.2.2. Powder
        11.2.3. Liquid
        11.2.4. Others
    11.3. Market Value Forecast, by Disease Type, 2017–2031
        11.3.1. Orphan Disease
            11.3.1.1. Duchenne Muscular Dystrophy (DMD)
            11.3.1.2. Sickle Cell Anemia
            11.3.1.3. Hemophilia
            11.3.1.4. Others
        11.3.2. Cancer
        11.3.3. Neurological & Psychological Disorders
        11.3.4. Metabolic Disorders
        11.3.5. Pain Management
        11.3.6. Gastrointestinal Disorders
        11.3.7. Ophthalmology
        11.3.8. Diabetes
        11.3.9. Phenylketonuria (PKU)
        11.3.10. Epilepsy
    11.4. Market Value Forecast, by Route of Administration, 2017–2031
        11.4.1. Oral
        11.4.2. Enteral
    11.5. Market Value Forecast, by Distribution Channel, 2017–2031
        11.5.1. Pharmacies & Drug Stores
        11.5.2. Online Channels
        11.5.3. Supermarkets & Hypermarkets
        11.5.4. Others
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product
        11.7.2. By Disease Type
        11.7.3. By Route of Administration
        11.7.4. By Distribution Channel
        11.7.5. By Country
12. Europe Medical Foods Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Pills
        12.2.2. Powder
        12.2.3. Liquid
        12.2.4. Others
    12.3. Market Value Forecast, by Disease Type, 2017–2031
        12.3.1. Orphan Disease
            12.3.1.1. Duchenne Muscular Dystrophy (DMD)
            12.3.1.2. Sickle Cell Anemia
            12.3.1.3. Hemophilia
            12.3.1.4. Others
        12.3.2. Cancer
        12.3.3. Neurological & Psychological Disorders
        12.3.4. Metabolic Disorders
        12.3.5. Pain Management
        12.3.6. Gastrointestinal Disorders
        12.3.7. Ophthalmology
        12.3.8. Diabetes
        12.3.9. Phenylketonuria (PKU)
        12.3.10. Epilepsy
    12.4. Market Value Forecast, by Route of Administration, 2017–2031
        12.4.1. Oral
        12.4.2. Enteral
    12.5. Market Value Forecast, by Distribution Channel, 2017–2031
        12.5.1. Pharmacies & Drug Stores
        12.5.2. Online Channels
        12.5.3. Supermarkets & Hypermarkets
        12.5.4. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. by Product Type
        12.7.2. By Disease Type
        12.7.3. By Route of Administration
        12.7.4. By Distribution Channel
        12.7.5. By Country/Sub-region
13. Asia Pacific Medical Foods Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Pills
        13.2.2. Powder
        13.2.3. Liquid
        13.2.4. Others
    13.3. Market Value Forecast, by Disease Type, 2017–2031
        13.3.1. Orphan Disease
            13.3.1.1. Duchenne Muscular Dystrophy (DMD)
            13.3.1.2. Sickle Cell Anemia
            13.3.1.3. Hemophilia
            13.3.1.4. Others
        13.3.2. Cancer
        13.3.3. Neurological & Psychological Disorders
        13.3.4. Metabolic Disorders
        13.3.5. Pain Management
        13.3.6. Gastrointestinal Disorders
        13.3.7. Ophthalmology
        13.3.8. Diabetes
        13.3.9. Phenylketonuria (PKU)
        13.3.10. Epilepsy
    13.4. Market Value Forecast, by Route of Administration, 2017–2031
        13.4.1. Oral
        13.4.2. Enteral
    13.5. Market Value Forecast, by Distribution Channel, 2017–2031
        13.5.1. Pharmacies & Drug Stores
        13.5.2. Online Channels
        13.5.3. Supermarkets & Hypermarkets
        13.5.4. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. by Product Type
        13.7.2. By Disease Type
        13.7.3. By Route of Administration
        13.7.4. By Distribution Channel
        13.7.5. By Country/Sub-region
14. Latin America Medical Foods Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Pills
        14.2.2. Powder
        14.2.3. Liquid
        14.2.4. Others
    14.3. Market Value Forecast, by Disease Type, 2017–2031
        14.3.1. Orphan Disease
            14.3.1.1. Duchenne Muscular Dystrophy (DMD)
            14.3.1.2. Sickle Cell Anemia
            14.3.1.3. Hemophilia
            14.3.1.4. Others
        14.3.2. Cancer
        14.3.3. Neurological & Psychological Disorders
        14.3.4. Metabolic Disorders
        14.3.5. Pain Management
        14.3.6. Gastrointestinal Disorders
        14.3.7. Ophthalmology
        14.3.8. Diabetes
        14.3.9. Phenylketonuria (PKU)
        14.3.10. Epilepsy
    14.4. Market Value Forecast, by Route of Administration, 2017–2031
        14.4.1. Oral
        14.4.2. Enteral
    14.5. Market Value Forecast, by Distribution Channel, 2017–2031
        14.5.1. Pharmacies & Drug Stores
        14.5.2. Online Channels
        14.5.3. Supermarkets & Hypermarkets
        14.5.4. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. by Product Type
        14.7.2. By Disease Type
        14.7.3. By Route of Administration
        14.7.4. By Distribution Channel
        14.7.5. By Country/Sub-region
15. Middle East & Africa Medical Foods Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product Type, 2017–2031
        15.2.1. Pills
        15.2.2. Powder
        15.2.3. Liquid
        15.2.4. Others
    15.3. Market Value Forecast, by Disease Type, 2017–2031
        15.3.1. Orphan Disease
            15.3.1.1. Duchenne Muscular Dystrophy (DMD)
            15.3.1.2. Sickle Cell Anemia
            15.3.1.3. Hemophilia
            15.3.1.4. Others
        15.3.2. Cancer
        15.3.3. Neurological & Psychological Disorders
        15.3.4. Metabolic Disorders
        15.3.5. Pain Management
        15.3.6. Gastrointestinal Disorders
        15.3.7. Ophthalmology
        15.3.8. Diabetes
        15.3.9. Phenylketonuria (PKU)
        15.3.10. Epilepsy
    15.4. Market Value Forecast, by Route of Administration, 2017–2031
        15.4.1. Oral
        15.4.2. Enteral
    15.5. Market Value Forecast, by Distribution Channel, 2017–2031
        15.5.1. Pharmacies & Drug Stores
        15.5.2. Online Channels
        15.5.3. Supermarkets & Hypermarkets
        15.5.4. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. by Product Type
        15.7.2. By Disease Type
        15.7.3. By Route of Administration
        15.7.4. By Distribution Channel
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player – Competition Matrix (by tier and size of companies)
    16.2. Competitive Business Strategies
    16.3. Company Profiles
        16.3.1. Nutricia (Danone)
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Nestlé S.A.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Abbott Laboratories
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Mead Johnson Nutrition
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Fresenius Kabi
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Friso
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Morinaga Milk Industry
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Primus Pharmaceuticals, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Targeted Medical Pharma, Inc.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Medtrition, Inc.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview

List of Tables

Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017–2031

Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031

Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031

Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031

Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 医療用食品の世界市場2023～2031：製品別、投与経路別(Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • カルシウムチャネル遮断薬の世界市場2023～2031：薬剤クラス別、用途別、投与経路別
  • 融合阻害剤の世界市場2022～2031：疾患別、投与経路別
  • 肝斑薬物治療の世界市場2023～2031：肝斑種類別、投与経路別、性別
  • 抗感染症薬の世界市場2023～2031：薬剤クラス別、投与経路別
  • 世界のギランバレー症候群（GBS）市場2023-2031：治療薬別（免疫グロブリン静注、血漿交換、その他）、投与経路別（経口、非経口）

    • ◆H&Iグローバルリサーチのお客様（例）◆